Tag Archives: Depression

Screening for Menopausal Depression: Are We Doing Enough?

Recent studies suggest that the burden of menopausal symptoms is greater than generally perceived.  About 80% of women experience vasomotor symptoms (VMS) – hot flashes and night sweats — as they transition into the menopause phase.  For many, the symptoms are manageable; however, a significant proportion of midlife women experience menopausal symptoms that negatively affect… Read More »

Dr Miriam Stoppard: Ketamine being used as depression drug that produces results within hours

Antidepressants can take a depressingly long time to kick in – a minimum of two weeks but often more like three to four. That waiting time can be ­disabling for patients, but what if an antidepressant could work in a day? Sounds far-fetched? It isn’t. Remember ketamine, that rather unpredictable street drug of the 90s?… Read More »

Sleep Apnea And Depression

The problems caused by sleep apnea are usually related to the poor obstructed sleep. For example we now know that people with sleep apnea have an increased incidence of cardiovascular disease and glaucoma. Now we are learning that sleep apnea is related to an increased incidence of depression and that treatment with a CPAP has… Read More »

Can psychedelics treat anorexia, depression? U.S. scientists get millions to find out

Since childhood, Rachael Petersen had lived with an unexplainable sense of grief that no drug or talk therapy could entirely ease. So in 2017 she volunteered for a small clinical trial at Johns Hopkins University that was testing psilocybin, the active ingredient in magic mushrooms, for chronic depression. “I was so depressed,” Petersen, 29, said… Read More »

In Brief: Dr. Elizabeth Fitelson on Distinguishing Postpartum Depression from the Blues

In our clinic, we see many women with postpartum depression.  Some women know that something is wrong fairly soon after the depression sets in, and they seek help; however, far too many women present long after the onset of the depression, convinced that they are just suffering from the blues.  In this interview, Dr. Elizabeth… Read More »

Brexanolone (Zulresso) for Postpartum Depression Cleared by the DEA, Now Available

Brexanolone, to be marketed by Sage Therapeutics as Zulresso, was initially approved in March 2019, as a treatment for postpartum depression.  At that time, we were told that Zulresso would be available in June 2019. Here are a few updates. The Drug Enforcement Administration (DEA) has recommended that brexanolone be placed in schedule IV of… Read More »

Veterans Agency to Offer New Depression Drug, Despite Cost and Safety Concerns

Confronted by a rising rate of suicides in some groups of veterans., the Department of Veterans Affairs on Friday decided to approve the use of a new and costly depression drug, despite concerns among doctors and other experts about the drug’s effectiveness. The decision to endorse the drug — called Spravato, and manufactured by Janssen,… Read More »

Increased Identification of Women with Perinatal Depression, But Still Room for Improvement

Over the last decade, public awareness of the mental health challenges women face has grown tremendously, and we can say with certainty that we have succeeded in putting this important topic firmly on the medical map.  Still, the field of women’s mental health faces important challenges. How can we best serve women and the clinicians… Read More »